Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 58,055,122	$ 35,300,805
Prepaid assets and other current assets	1,721,184	2,258,229
Total current assets	59,776,306	37,559,034
Property and equipment, net	1,577,441	1,102,808
Total assets	61,353,747	38,661,842
Current liabilities:
Accounts payable	1,817,034	1,297,725
Deferred research grant revenue		24,315
Total liabilities	1,817,034	1,322,040
Commitments and contingencies (see Note 4)
Stockholders’ equity:
Common stock; $0.001 par value, 45,000,000 shares authorized; 25,364,281 and 22,534,874 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively	25,364	22,535
Additional paid-in capital	101,535,068	71,648,453
Accumulated other comprehensive loss	(89,496)	(51,538)
Accumulated deficit	(41,934,223)	(34,279,648)
Total stockholders’ equity	59,536,713	37,339,802
Total liabilities and stockholders’ equity	$ 61,353,747	$ 38,661,842